The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Highlights
The global Nocturnal Enuresis Medication market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.
The major global companies of Nocturnal Enuresis Medication include Allergan, Ferring Pharmaceuticals, Inc., Pfizer Inc., Janssen Pharmaceuticals, Inc., Urovant Sciences, Inc., Astellas Pharma US, Inc., Bayer Corp, Mallinckrodt, Inc. and Shanghai Xudong Haipu Pharmaceutical Co., Ltd, etc. In 2021, the world's top three vendors accounted for approximately % of the revenue.
Considering the economic change due to COVID-19, Desmopressin(DDAVP), which accounted for % of the global market of Nocturnal Enuresis Medication in 2021, is expected to reach US$ million by 2028, growing at a revised CAGR of % from 2022 to 2028.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Nocturnal Enuresis Medication, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nocturnal Enuresis Medication.
The Nocturnal Enuresis Medication market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Nocturnal Enuresis Medication market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nocturnal Enuresis Medication companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Some of the prominent players reviewed in the research report include:
- Allergan
- Ferring Pharmaceuticals, Inc.
- Pfizer Inc.
- Janssen Pharmaceuticals, Inc.
- Urovant Sciences, Inc.
- Astellas Pharma US, Inc.
- Bayer Corp
- Mallinckrodt, Inc.
- Shanghai Xudong Haipu Pharmaceutical Co., Ltd
- Guangdong Xianqiang Pharmaceutical Co., Ltd
- Beijing Zizhu Pharmaceutical Co., Ltd
- Shanghai Pharmaceutical Group
Product Type Insights
Global markets are presented by Nocturnal Enuresis Medication type, along with growth forecasts through 2028. Estimates on revenue are based on the price in the supply chain at which the Nocturnal Enuresis Medication are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).
Nocturnal Enuresis Medication segment by Type
- Desmopressin(DDAVP)
- Tofranil
- Others
Application Insights
This report has provided the market size (revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Nocturnal Enuresis Medication market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Nocturnal Enuresis Medication market.
Nocturnal Enuresis Medication Segment by Application
- Hospital
- Specialist Clinic
- Others
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina, Colombia)
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Nocturnal Enuresis Medication market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
- This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nocturnal Enuresis Medication market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
- This report will help stakeholders to understand the global industry status and trends of Nocturnal Enuresis Medication and provides them with information on key market drivers, restraints, challenges, and opportunities.
- This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
- This report stays updated with novel technology integration, features, and the latest developments in the market
- This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Nocturnal Enuresis Medication industry.
- This report helps stakeholders to gain insights into which regions to target globally
- This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nocturnal Enuresis Medication.
- This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nocturnal Enuresis Medication companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nocturnal Enuresis Medication Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Desmopressin(DDAVP)
1.2.3 Tofranil
1.2.4 Others
1.3 Market by Application
1.3.1 Global Nocturnal Enuresis Medication Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Specialist Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Nocturnal Enuresis Medication Market Perspective (2017-2028)
2.2 Nocturnal Enuresis Medication Growth Trends by Region
2.2.1 Nocturnal Enuresis Medication Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Nocturnal Enuresis Medication Historic Market Size by Region (2017-2022)
2.2.3 Nocturnal Enuresis Medication Forecasted Market Size by Region (2023-2028)
2.3 Nocturnal Enuresis Medication Market Dynamics
2.3.1 Nocturnal Enuresis Medication Industry Trends
2.3.2 Nocturnal Enuresis Medication Market Drivers
2.3.3 Nocturnal Enuresis Medication Market Challenges
2.3.4 Nocturnal Enuresis Medication Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nocturnal Enuresis Medication Players by Revenue
3.1.1 Global Top Nocturnal Enuresis Medication Players by Revenue (2017-2022)
3.1.2 Global Nocturnal Enuresis Medication Revenue Market Share by Players (2017-2022)
3.2 Global Nocturnal Enuresis Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nocturnal Enuresis Medication Revenue
3.4 Global Nocturnal Enuresis Medication Market Concentration Ratio
3.4.1 Global Nocturnal Enuresis Medication Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nocturnal Enuresis Medication Revenue in 2021
3.5 Nocturnal Enuresis Medication Key Players Head office and Area Served
3.6 Key Players Nocturnal Enuresis Medication Product Solution and Service
3.7 Date of Enter into Nocturnal Enuresis Medication Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nocturnal Enuresis Medication Breakdown Data by Type
4.1 Global Nocturnal Enuresis Medication Historic Market Size by Type (2017-2022)
4.2 Global Nocturnal Enuresis Medication Forecasted Market Size by Type (2023-2028)
5 Nocturnal Enuresis Medication Breakdown Data by Application
5.1 Global Nocturnal Enuresis Medication Historic Market Size by Application (2017-2022)
5.2 Global Nocturnal Enuresis Medication Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Nocturnal Enuresis Medication Market Size (2017-2028)
6.2 North America Nocturnal Enuresis Medication Market Size by Country (2017-2022)
6.3 North America Nocturnal Enuresis Medication Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Nocturnal Enuresis Medication Market Size (2017-2028)
7.2 Europe Nocturnal Enuresis Medication Market Size by Country (2017-2022)
7.3 Europe Nocturnal Enuresis Medication Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nocturnal Enuresis Medication Market Size (2017-2028)
8.2 Asia-Pacific Nocturnal Enuresis Medication Market Size by Country (2017-2022)
8.3 Asia-Pacific Nocturnal Enuresis Medication Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Nocturnal Enuresis Medication Market Size (2017-2028)
9.2 Latin America Nocturnal Enuresis Medication Market Size by Country (2017-2022)
9.3 Latin America Nocturnal Enuresis Medication Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nocturnal Enuresis Medication Market Size (2017-2028)
10.2 Middle East & Africa Nocturnal Enuresis Medication Market Size by Country (2017-2022)
10.3 Middle East & Africa Nocturnal Enuresis Medication Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Allergan
11.1.1 Allergan Company Detail
11.1.2 Allergan Business Overview
11.1.3 Allergan Nocturnal Enuresis Medication Introduction
11.1.4 Allergan Revenue in Nocturnal Enuresis Medication Business (2017-2022)
11.1.5 Allergan Recent Development
11.2 Ferring Pharmaceuticals, Inc.
11.2.1 Ferring Pharmaceuticals, Inc. Company Detail
11.2.2 Ferring Pharmaceuticals, Inc. Business Overview
11.2.3 Ferring Pharmaceuticals, Inc. Nocturnal Enuresis Medication Introduction
11.2.4 Ferring Pharmaceuticals, Inc. Revenue in Nocturnal Enuresis Medication Business (2017-2022)
11.2.5 Ferring Pharmaceuticals, Inc. Recent Development
11.3 Pfizer Inc.
11.3.1 Pfizer Inc. Company Detail
11.3.2 Pfizer Inc. Business Overview
11.3.3 Pfizer Inc. Nocturnal Enuresis Medication Introduction
11.3.4 Pfizer Inc. Revenue in Nocturnal Enuresis Medication Business (2017-2022)
11.3.5 Pfizer Inc. Recent Development
11.4 Janssen Pharmaceuticals, Inc.
11.4.1 Janssen Pharmaceuticals, Inc. Company Detail
11.4.2 Janssen Pharmaceuticals, Inc. Business Overview
11.4.3 Janssen Pharmaceuticals, Inc. Nocturnal Enuresis Medication Introduction
11.4.4 Janssen Pharmaceuticals, Inc. Revenue in Nocturnal Enuresis Medication Business (2017-2022)
11.4.5 Janssen Pharmaceuticals, Inc. Recent Development
11.5 Urovant Sciences, Inc.
11.5.1 Urovant Sciences, Inc. Company Detail
11.5.2 Urovant Sciences, Inc. Business Overview
11.5.3 Urovant Sciences, Inc. Nocturnal Enuresis Medication Introduction
11.5.4 Urovant Sciences, Inc. Revenue in Nocturnal Enuresis Medication Business (2017-2022)
11.5.5 Urovant Sciences, Inc. Recent Development
11.6 Astellas Pharma US, Inc.
11.6.1 Astellas Pharma US, Inc. Company Detail
11.6.2 Astellas Pharma US, Inc. Business Overview
11.6.3 Astellas Pharma US, Inc. Nocturnal Enuresis Medication Introduction
11.6.4 Astellas Pharma US, Inc. Revenue in Nocturnal Enuresis Medication Business (2017-2022)
11.6.5 Astellas Pharma US, Inc. Recent Development
11.7 Bayer Corp
11.7.1 Bayer Corp Company Detail
11.7.2 Bayer Corp Business Overview
11.7.3 Bayer Corp Nocturnal Enuresis Medication Introduction
11.7.4 Bayer Corp Revenue in Nocturnal Enuresis Medication Business (2017-2022)
11.7.5 Bayer Corp Recent Development
11.8 Mallinckrodt, Inc.
11.8.1 Mallinckrodt, Inc. Company Detail
11.8.2 Mallinckrodt, Inc. Business Overview
11.8.3 Mallinckrodt, Inc. Nocturnal Enuresis Medication Introduction
11.8.4 Mallinckrodt, Inc. Revenue in Nocturnal Enuresis Medication Business (2017-2022)
11.8.5 Mallinckrodt, Inc. Recent Development
11.9 Shanghai Xudong Haipu Pharmaceutical Co., Ltd
11.9.1 Shanghai Xudong Haipu Pharmaceutical Co., Ltd Company Detail
11.9.2 Shanghai Xudong Haipu Pharmaceutical Co., Ltd Business Overview
11.9.3 Shanghai Xudong Haipu Pharmaceutical Co., Ltd Nocturnal Enuresis Medication Introduction
11.9.4 Shanghai Xudong Haipu Pharmaceutical Co., Ltd Revenue in Nocturnal Enuresis Medication Business (2017-2022)
11.9.5 Shanghai Xudong Haipu Pharmaceutical Co., Ltd Recent Development
11.10 Guangdong Xianqiang Pharmaceutical Co., Ltd
11.10.1 Guangdong Xianqiang Pharmaceutical Co., Ltd Company Detail
11.10.2 Guangdong Xianqiang Pharmaceutical Co., Ltd Business Overview
11.10.3 Guangdong Xianqiang Pharmaceutical Co., Ltd Nocturnal Enuresis Medication Introduction
11.10.4 Guangdong Xianqiang Pharmaceutical Co., Ltd Revenue in Nocturnal Enuresis Medication Business (2017-2022)
11.10.5 Guangdong Xianqiang Pharmaceutical Co., Ltd Recent Development
11.11 Beijing Zizhu Pharmaceutical Co., Ltd
11.11.1 Beijing Zizhu Pharmaceutical Co., Ltd Company Detail
11.11.2 Beijing Zizhu Pharmaceutical Co., Ltd Business Overview
11.11.3 Beijing Zizhu Pharmaceutical Co., Ltd Nocturnal Enuresis Medication Introduction
11.11.4 Beijing Zizhu Pharmaceutical Co., Ltd Revenue in Nocturnal Enuresis Medication Business (2017-2022)
11.11.5 Beijing Zizhu Pharmaceutical Co., Ltd Recent Development
11.12 Shanghai Pharmaceutical Group
11.12.1 Shanghai Pharmaceutical Group Company Detail
11.12.2 Shanghai Pharmaceutical Group Business Overview
11.12.3 Shanghai Pharmaceutical Group Nocturnal Enuresis Medication Introduction
11.12.4 Shanghai Pharmaceutical Group Revenue in Nocturnal Enuresis Medication Business (2017-2022)
11.12.5 Shanghai Pharmaceutical Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global Nocturnal Enuresis Medication Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Desmopressin(DDAVP)
Table 3. Key Players of Tofranil
Table 4. Key Players of Others
Table 5. Global Nocturnal Enuresis Medication Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Nocturnal Enuresis Medication Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Nocturnal Enuresis Medication Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Nocturnal Enuresis Medication Market Share by Region (2017-2022)
Table 9. Global Nocturnal Enuresis Medication Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Nocturnal Enuresis Medication Market Share by Region (2023-2028)
Table 11. Nocturnal Enuresis Medication Market Trends
Table 12. Nocturnal Enuresis Medication Market Drivers
Table 13. Nocturnal Enuresis Medication Market Challenges
Table 14. Nocturnal Enuresis Medication Market Restraints
Table 15. Global Nocturnal Enuresis Medication Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Nocturnal Enuresis Medication Market Share by Players (2017-2022)
Table 17. Global Top Nocturnal Enuresis Medication Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nocturnal Enuresis Medication as of 2021)
Table 18. Ranking of Global Top Nocturnal Enuresis Medication Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Nocturnal Enuresis Medication Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Nocturnal Enuresis Medication Product Solution and Service
Table 22. Date of Enter into Nocturnal Enuresis Medication Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Nocturnal Enuresis Medication Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Nocturnal Enuresis Medication Revenue Market Share by Type (2017-2022)
Table 26. Global Nocturnal Enuresis Medication Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Nocturnal Enuresis Medication Revenue Market Share by Type (2023-2028)
Table 28. Global Nocturnal Enuresis Medication Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Nocturnal Enuresis Medication Revenue Market Share by Application (2017-2022)
Table 30. Global Nocturnal Enuresis Medication Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Nocturnal Enuresis Medication Revenue Market Share by Application (2023-2028)
Table 32. North America Nocturnal Enuresis Medication Market Size by Country (2017-2022) & (US$ Million)
Table 33. North America Nocturnal Enuresis Medication Market Size by Country (2023-2028) & (US$ Million)
Table 34. Europe Nocturnal Enuresis Medication Market Size by Country (2017-2022) & (US$ Million)
Table 35. Europe Nocturnal Enuresis Medication Market Size by Country (2023-2028) & (US$ Million)
Table 36. Asia-Pacific Nocturnal Enuresis Medication Market Size by Region (2017-2022) & (US$ Million)
Table 37. Asia-Pacific Nocturnal Enuresis Medication Market Size by Region (2023-2028) & (US$ Million)
Table 38. Latin America Nocturnal Enuresis Medication Market Size by Country (2017-2022) & (US$ Million)
Table 39. Latin America Nocturnal Enuresis Medication Market Size by Country (2023-2028) & (US$ Million)
Table 40. Middle East & Africa Nocturnal Enuresis Medication Market Size by Country (2017-2022) & (US$ Million)
Table 41. Middle East & Africa Nocturnal Enuresis Medication Market Size by Country (2023-2028) & (US$ Million)
Table 42. Allergan Company Detail
Table 43. Allergan Business Overview
Table 44. Allergan Nocturnal Enuresis Medication Product
Table 45. Allergan Revenue in Nocturnal Enuresis Medication Business (2017-2022) & (US$ Million)
Table 46. Allergan Recent Development
Table 47. Ferring Pharmaceuticals, Inc. Company Detail
Table 48. Ferring Pharmaceuticals, Inc. Business Overview
Table 49. Ferring Pharmaceuticals, Inc. Nocturnal Enuresis Medication Product
Table 50. Ferring Pharmaceuticals, Inc. Revenue in Nocturnal Enuresis Medication Business (2017-2022) & (US$ Million)
Table 51. Ferring Pharmaceuticals, Inc. Recent Development
Table 52. Pfizer Inc. Company Detail
Table 53. Pfizer Inc. Business Overview
Table 54. Pfizer Inc. Nocturnal Enuresis Medication Product
Table 55. Pfizer Inc. Revenue in Nocturnal Enuresis Medication Business (2017-2022) & (US$ Million)
Table 56. Pfizer Inc. Recent Development
Table 57. Janssen Pharmaceuticals, Inc. Company Detail
Table 58. Janssen Pharmaceuticals, Inc. Business Overview
Table 59. Janssen Pharmaceuticals, Inc. Nocturnal Enuresis Medication Product
Table 60. Janssen Pharmaceuticals, Inc. Revenue in Nocturnal Enuresis Medication Business (2017-2022) & (US$ Million)
Table 61. Janssen Pharmaceuticals, Inc. Recent Development
Table 62. Urovant Sciences, Inc. Company Detail
Table 63. Urovant Sciences, Inc. Business Overview
Table 64. Urovant Sciences, Inc. Nocturnal Enuresis Medication Product
Table 65. Urovant Sciences, Inc. Revenue in Nocturnal Enuresis Medication Business (2017-2022) & (US$ Million)
Table 66. Urovant Sciences, Inc. Recent Development
Table 67. Astellas Pharma US, Inc. Company Detail
Table 68. Astellas Pharma US, Inc. Business Overview
Table 69. Astellas Pharma US, Inc. Nocturnal Enuresis Medication Product
Table 70. Astellas Pharma US, Inc. Revenue in Nocturnal Enuresis Medication Business (2017-2022) & (US$ Million)
Table 71. Astellas Pharma US, Inc. Recent Development
Table 72. Bayer Corp Company Detail
Table 73. Bayer Corp Business Overview
Table 74. Bayer Corp Nocturnal Enuresis Medication Product
Table 75. Bayer Corp Revenue in Nocturnal Enuresis Medication Business (2017-2022) & (US$ Million)
Table 76. Bayer Corp Recent Development
Table 77. Mallinckrodt, Inc. Company Detail
Table 78. Mallinckrodt, Inc. Business Overview
Table 79. Mallinckrodt, Inc. Nocturnal Enuresis Medication Product
Table 80. Mallinckrodt, Inc. Revenue in Nocturnal Enuresis Medication Business (2017-2022) & (US$ Million)
Table 81. Mallinckrodt, Inc. Recent Development
Table 82. Shanghai Xudong Haipu Pharmaceutical Co., Ltd Company Detail
Table 83. Shanghai Xudong Haipu Pharmaceutical Co., Ltd Business Overview
Table 84. Shanghai Xudong Haipu Pharmaceutical Co., Ltd Nocturnal Enuresis Medication Product
Table 85. Shanghai Xudong Haipu Pharmaceutical Co., Ltd Revenue in Nocturnal Enuresis Medication Business (2017-2022) & (US$ Million)
Table 86. Shanghai Xudong Haipu Pharmaceutical Co., Ltd Recent Development
Table 87. Guangdong Xianqiang Pharmaceutical Co., Ltd Company Detail
Table 88. Guangdong Xianqiang Pharmaceutical Co., Ltd Business Overview
Table 89. Guangdong Xianqiang Pharmaceutical Co., Ltd Nocturnal Enuresis Medication Product
Table 90. Guangdong Xianqiang Pharmaceutical Co., Ltd Revenue in Nocturnal Enuresis Medication Business (2017-2022) & (US$ Million)
Table 91. Guangdong Xianqiang Pharmaceutical Co., Ltd Recent Development
Table 92. Beijing Zizhu Pharmaceutical Co., Ltd Company Detail
Table 93. Beijing Zizhu Pharmaceutical Co., Ltd Business Overview
Table 94. Beijing Zizhu Pharmaceutical Co., Ltd Nocturnal Enuresis MedicationProduct
Table 95. Beijing Zizhu Pharmaceutical Co., Ltd Revenue in Nocturnal Enuresis Medication Business (2017-2022) & (US$ Million)
Table 96. Beijing Zizhu Pharmaceutical Co., Ltd Recent Development
Table 97. Shanghai Pharmaceutical Group Company Detail
Table 98. Shanghai Pharmaceutical Group Business Overview
Table 99. Shanghai Pharmaceutical Group Nocturnal Enuresis MedicationProduct
Table 100. Shanghai Pharmaceutical Group Revenue in Nocturnal Enuresis Medication Business (2017-2022) & (US$ Million)
Table 101. Shanghai Pharmaceutical Group Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nocturnal Enuresis Medication Market Share by Type: 2021 VS 2028
Figure 2. Desmopressin(DDAVP) Features
Figure 3. Tofranil Features
Figure 4. Others Features
Figure 5. Global Nocturnal Enuresis Medication Market Share by Application in 2021 & 2028
Figure 6. Hospital Case Studies
Figure 7. Specialist Clinic Case Studies
Figure 8. Others Case Studies
Figure 9. Nocturnal Enuresis Medication Report Years Considered
Figure 10. Global Nocturnal Enuresis Medication Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Nocturnal Enuresis Medication Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Nocturnal Enuresis Medication Market Share by Region: 2021 VS 2028
Figure 13. Global Nocturnal Enuresis Medication Market Share by Players in 2021
Figure 14. Global Top Nocturnal Enuresis Medication Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nocturnal Enuresis Medication as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Nocturnal Enuresis Medication Revenue in 2021
Figure 16. North America Nocturnal Enuresis Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 17. North America Nocturnal Enuresis Medication Market Share by Country (2017-2028)
Figure 18. United States Nocturnal Enuresis Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Canada Nocturnal Enuresis Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Nocturnal Enuresis Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Nocturnal Enuresis Medication Market Share by Country (2017-2028)
Figure 22. Germany Nocturnal Enuresis Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. France Nocturnal Enuresis Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. U.K. Nocturnal Enuresis Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Italy Nocturnal Enuresis Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Russia Nocturnal Enuresis Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Nordic Countries Nocturnal Enuresis Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Nocturnal Enuresis Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Nocturnal Enuresis Medication Market Share by Region (2017-2028)
Figure 30. China Nocturnal Enuresis Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Japan Nocturnal Enuresis Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. South Korea Nocturnal Enuresis Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Southeast Asia Nocturnal Enuresis Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. India Nocturnal Enuresis Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Australia Nocturnal Enuresis Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Nocturnal Enuresis Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Nocturnal Enuresis Medication Market Share by Country (2017-2028)
Figure 38. Mexico Nocturnal Enuresis Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Brazil Nocturnal Enuresis Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Nocturnal Enuresis Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Nocturnal Enuresis Medication Market Share by Country (2017-2028)
Figure 42. Turkey Nocturnal Enuresis Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Saudi Arabia Nocturnal Enuresis Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Allergan Revenue Growth Rate in Nocturnal Enuresis Medication Business (2017-2022)
Figure 45. Ferring Pharmaceuticals, Inc. Revenue Growth Rate in Nocturnal Enuresis Medication Business (2017-2022)
Figure 46. Pfizer Inc. Revenue Growth Rate in Nocturnal Enuresis Medication Business (2017-2022)
Figure 47. Janssen Pharmaceuticals, Inc. Revenue Growth Rate in Nocturnal Enuresis Medication Business (2017-2022)
Figure 48. Urovant Sciences, Inc. Revenue Growth Rate in Nocturnal Enuresis Medication Business (2017-2022)
Figure 49. Astellas Pharma US, Inc. Revenue Growth Rate in Nocturnal Enuresis Medication Business (2017-2022)
Figure 50. Bayer Corp Revenue Growth Rate in Nocturnal Enuresis Medication Business (2017-2022)
Figure 51. Mallinckrodt, Inc. Revenue Growth Rate in Nocturnal Enuresis Medication Business (2017-2022)
Figure 52. Shanghai Xudong Haipu Pharmaceutical Co., Ltd Revenue Growth Rate in Nocturnal Enuresis Medication Business (2017-2022)
Figure 53. Guangdong Xianqiang Pharmaceutical Co., Ltd Revenue Growth Rate in Nocturnal Enuresis Medication Business (2017-2022)
Figure 54. Beijing Zizhu Pharmaceutical Co., Ltd Revenue Growth Rate in Nocturnal Enuresis Medication Business (2017-2022)
Figure 55. Shanghai Pharmaceutical Group Revenue Growth Rate in Nocturnal Enuresis Medication Business (2017-2022)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
